BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1317775)

  • 1. Angiotensin-II acts via the type 1 receptor to inhibit 17 alpha-hydroxylase cytochrome P450 expression in ovine adrenocortical cells.
    Bird IM; Magness RR; Mason JI; Rainey WE
    Endocrinology; 1992 Jun; 130(6):3113-21. PubMed ID: 1317775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-II stimulates an increase in cAMP and expression of 17 alpha-hydroxylase cytochrome P450 in fetal bovine adrenocortical cells.
    Bird IM; Mason JI; Oka K; Rainey WE
    Endocrinology; 1993 Feb; 132(2):932-4. PubMed ID: 8381079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of angiotensin II type 1 receptor expression and AT1-R mRNA levels in human adrenocortical cells.
    Bird IM; Mason JI; Rainey WE
    Endocr Res; 1995; 21(1-2):169-82. PubMed ID: 7588378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cultured adrenal fasciculata-reticularis cells are targets for angiotensin-II: effects on cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase, and 3 beta-hydroxysteroid-dehydrogenase messenger ribonucleic acid and proteins and on steroidogenic responsiveness to corticotropin and angiotensin-II.
    Lebrethon MC; Jaillard C; Defayes G; Begeot M; Saez JM
    J Clin Endocrinol Metab; 1994 May; 78(5):1212-9. PubMed ID: 8175981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II stimulates growth and steroidogenesis in zona fasciculata/reticularis cells from bovine adrenal cortex via the AT1 receptor subtype.
    Clyne CD; Nicol MR; MacDonald S; Williams BC; Walker SW
    Endocrinology; 1993 May; 132(5):2206-12. PubMed ID: 8386614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells.
    Bird IM; Imaishi K; Pasquarette MM; Rainey WE; Mason JI
    J Endocrinol; 1996 Sep; 150 Suppl():S165-73. PubMed ID: 8943800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and regulation of the angiotensin II type-1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells.
    Naville D; Lebrethon MC; Kermabon AY; Rouer E; Benarous R; Saez JM
    FEBS Lett; 1993 Apr; 321(2-3):184-8. PubMed ID: 8477848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
    Boulay G; Servant G; Luong TT; Escher E; Guillemette G
    Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells.
    Bird IM; Pasquarette MM; Rainey WE; Mason JI
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2171-8. PubMed ID: 8964847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta inhibits steroid 17 alpha-hydroxylase cytochrome P-450 expression in ovine adrenocortical cells.
    Rainey WE; Naville D; Saez JM; Carr BR; Byrd W; Magness RR; Mason JI
    Endocrinology; 1990 Oct; 127(4):1910-5. PubMed ID: 2169408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
    Balla T; Baukal AJ; Eng S; Catt KJ
    Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 3 beta-hydroxysteroid dehydrogenase in adrenocortical cells: effects of angiotensin-II and transforming growth factor beta.
    Rainey WE; Naville D; Mason JI
    Endocr Res; 1991; 17(1-2):281-96. PubMed ID: 1652433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II and transforming growth factor-beta.
    Rainey WE; Oka K; Magness RR; Mason JI
    Endocrinology; 1991 Oct; 129(4):1784-90. PubMed ID: 1655383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells.
    Ouali R; LeBrethon MC; Saez JM
    Endocrinology; 1993 Dec; 133(6):2766-72. PubMed ID: 8243303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel angiotensin receptor subtypes in fowl.
    Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-fos, c-jun and jun-B messenger ribonucleic acids by angiotensin-II and corticotropin in ovine and bovine adrenocortical cells.
    Viard I; Hall SH; Jaillard C; Berthelon MC; Saez JM
    Endocrinology; 1992 Mar; 130(3):1193-200. PubMed ID: 1311231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
    Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1996 Apr; 97(8):1978-82. PubMed ID: 8621783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan-sensitive AII receptors linked to depolarization-dependent cortisol secretion through a novel signaling pathway.
    Mlinar B; Biagi BA; Enyeart JJ
    J Biol Chem; 1995 Sep; 270(36):20942-51. PubMed ID: 7673118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon inhibits ACTH-stimulated cortisol secretion from dispersed human adrenocortical cells by activating unidentified receptors negatively coupled with the adenylate cyclase cascade.
    Mazzocchi G; Gottardo L; Aragona F; Albertin G; Nussdorfer GG
    Horm Metab Res; 2000 Jul; 32(7):265-8. PubMed ID: 10965931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.